Recurrent Prostate Cancer
Conditions
Keywords
Recurrent Prostate Cancer
Brief summary
Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to endorse their broader utilization. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with recurrent prostate cancer.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient is at least 18 years of age * Diagnosis of recurrent prostate cancer * Ability to understand and the willingness to sign a written informed consent document
Exclusion criteria
* Enrolled in another research study * Patients with psychiatric illness/social situations that would limit compliance with study requirements * Inability to provide written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to participate in a recurrent prostate cancer clinical research | 3 months |
| Rate of patients who remain in recurrent prostate cancer clinical research to trial completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed